Research Topics
| Mark S SlaughterSummaryAffiliation: University of Louisville Country: USA Publications
| Collaborators
|
Detail Information
Publications
Increase in circadian variation after continuous-flow ventricular assist device implantationMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
J Heart Lung Transplant 29:695-7. 2010..The return of the circadian rhythm has implications for cardiac recovery, and the observation indicates that the continuous-flow LVAD has an intrinsic automatic response to physiologic demands...
Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospectsMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
J Card Surg 25:484-9. 2010..A totally implantable LVAD with an incorporated TETS for destination therapy could become an important advance in the treatment of end-stage heart failure...
Transapical miniaturized ventricular assist device: design and initial testingMark S Slaughter
Department of Surgery, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
J Thorac Cardiovasc Surg 142:668-74. 2011..We evaluated a new miniaturized left ventricular assist device that requires minimal surgery for implantation, potentially allowing implantation in earlier stage heart failure...
Platelet activation in heart failure patients supported by the HeartMate II ventricular assist deviceMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
Int J Artif Organs 34:461-8. 2011..In this study, markers of platelet activation were investigated in HF patients supported by a HeartMate II left ventricular assist device (LVAD)...
Reducing emboli in cardiac surgery: does it make a difference?Mark S Slaughter
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
Artif Organs 32:880-4. 2008....
The total artificial heartA Meyer
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, KY, USA
Panminerva Med 53:141-54. 2011..In this review article, a brief history on the evolution of TAH devices, their current use and emerging use of evolving continuous flow VAD technology as chronic biventricular and TAH device systems are presented...
Intraoperative evaluation of the HeartMate II flow estimatorMark S Slaughter
Division of Cardiothoracic Surgery, Cardiovascular Innovation Institute, University of Louisville, Kentucky, USA
J Heart Lung Transplant 28:39-43. 2009..This study evaluated the accuracy of HeartMate II flow estimation at the time of implantation...
Temporal changes in hospital costs for left ventricular assist device implantationMark S Slaughter
Division of Cardiothoracic Surgery, University of Louisville, KY 40202, USA
J Card Surg 26:535-41. 2011..The current study examines the hospitalization costs associated with treatment of New York Heart Failure Class IV patients when implanted with a CF LVAD and compares them to previously reported costs of a PF LVAD in the same population...
Destination therapy with left ventricular assist devices: patient selection and outcomesMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40202, USA
Curr Opin Cardiol 26:232-6. 2011..With the advent of continuous-flow LVADs, safe and effective long-term circulatory support is available for properly identified candidates...
Advanced heart failure treated with continuous-flow left ventricular assist deviceMark S Slaughter
Advocate Christ Medical Center, Oak Lawn, IL, USA
N Engl J Med 361:2241-51. 2009..New continuous-flow devices are smaller and may be more durable than the pulsatile-flow devices...
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapyMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
J Heart Lung Transplant 29:616-24. 2010..We retrospectively evaluated the effects of heparin use on thromboembolic and bleeding complications after implantation of the HeartMate II left ventricular assist device (LVAD)...
Implantation of the HeartWare left ventricular assist deviceMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky, USA
Semin Thorac Cardiovasc Surg 23:245-7. 2011..The HeartWare HVAD is a new continuous flow LVAD, currently in trials, that is designed to be implanted and contained completely within the pericardial space...
Evaluation of new Forcefield technology: reducing platelet adhesion and cell coverage of pyrolytic carbon surfacesMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY, USA
J Thorac Cardiovasc Surg 142:921-5. 2011..A modulated low-voltage current is directly applied to pyrolytic carbon surfaces to stimulate adherence of a layer of charged proteins from circulating blood components that is resistive to platelet deposition...
Hematologic effects of continuous flow left ventricular assist devicesMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40202, USA
J Cardiovasc Transl Res 3:618-24. 2010..Because bleeding causes significant morbidity for this population, more effective treatment strategies need to be developed...
Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapyMark S Slaughter
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
J Card Surg 25:490-4. 2010..Current clinical evidence indicates that end-organ perfusion and function can be well maintained for extended durations of support with a CF-LVAD...
Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist deviceMark S Slaughter
Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
Tex Heart Inst J 35:245-9. 2008..They also suggest that modifications made to the HeartMate LVAD since the REMATCH trial have resulted in fewer complications, and that better patient selection and supportive care have improved outcomes...
Human, bovine and porcine systematic vascular input impedances are not equivalent: implications for device testing and xenotransplantation in heart failureSteven C Koenig
Cardiovascular Innovation Institute, Department of Bioengineering and Surgery, University of Louisville, Louisville, Kentucky 502 852 1795, USA
J Heart Lung Transplant 27:1340-7. 2008..Systemic aortic input impedance (Z(ART)) is an important physiologic determinant of left ventricular (LV) performance. We tested the hypothesis that Z(ART) is lower in bovine and porcine than in humans with normal or failing hearts...
Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac functionSteven C Koenig
Department of Bioengineering, Cardiovascular Innovation Institute, University of Louisville, Louisville, Kentucky 40202, USA
ASAIO J 54:578-84. 2008..The CPD provides hemodynamic efficacy equivalent to an IABP and may become a therapeutic option for patients who may benefit from prolonged counterpulsation...
HeartWare miniature axial-flow ventricular assist device: design and initial feasibility testMark S Slaughter
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
Tex Heart Inst J 36:12-6. 2009..Further in vivo testing is planned. Herein, we discuss the unique design of the HeartWare miniature ventricular assist device, our feasibility study of its performance, and the possibilities for its use in human beings...
Heart transplant vs left ventricular assist device in heart transplant-eligible patientsMatthew L Williams
Division of Thoracic and Cardiovascular Surgery, University of Louisville, and Jewish Hospital Transplant Center, Louisville, Kentucky 40202, USA
Ann Thorac Surg 91:1330-3; discussion 1333-4. 2011..We evaluated 1-year outcome and effectiveness of LVAD vs heart transplantation...
Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist deviceAdam R Travis
Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
J Thorac Cardiovasc Surg 133:517-24. 2007....
Managing mechanical valves with reduced anticoagulationMark S Slaughter
Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
Expert Rev Cardiovasc Ther 5:1073-85. 2007..The current trend is more frequent use of bioprosthetic valves; however, this trend may again reverse as therapy for mechanical valves is refined...
Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricleCarlo R Bartoli
University of Louisville School of Medicine, Kentucky, USA
ASAIO J 56:410-6. 2010..These findings may have important implications for chronic LVAD therapy...
Destination therapy: safety and feasibility of national and international travelLaura A Coyle
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
ASAIO J 54:172-6. 2008..All patients returned home safely for routine follow-up. Long-distance travel is possible for DT patients. Anticipating potential problems and careful planning is necessary for safe national and international travel...
A novel subcutaneous counterpulsation device: acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failureCarlo R Bartoli
MD PhD Program, University of Louisville School of Medicine, Louisville, KY, USA
Artif Organs 34:537-45. 2010..A novel 32-mL CPD connected to a peripheral artery produced equivalent or greater hemodynamic benefits than a standard 40-mL IABP during pharmacologically induced hypertension, hypotension, and heart failure conditions...
Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocolsMark S Slaughter
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
ASAIO J 52:228-33. 2006..The long-term effects of steady-state and transient LV mechanical reloading on myocardial structure and function toward achieving sustained myocardial recovery warrant further investigation...
Peripheral cardiopulmonary bypass with modified assisted venous drainage and transthoracic aortic crossclamp: optimal management for robotic mitral valve repairMichael A Sobieski
Division of Cardiac Surgery, Christ Hospital and Medical Center, Oak Lawn, IL, USA
Perfusion 18:307-11. 2003..This approach may be applied to other forms of minimally invasive cardiac surgery that requires CPB...
Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator useMichael A Sobieski
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
Perfusion 20:31-7. 2005..Evaluate the feasibility and clinical significance of crystalloid prime reduction during the initiation of cardiopulmonary bypass (CPB) using a modified bridge on the cardioplegia delivery system...
Clinical management of continuous-flow left ventricular assist devices in advanced heart failureMark S Slaughter
University of Louisville, Louisville, Kentucky, USA
J Heart Lung Transplant 29:S1-39. 2010..Ongoing trials with other continuous-flow devices may produce additional information in the future for improving clinical management of patients with these devices...
Destination therapy: one-year outcomes in patients with a body mass index greater than 30Laura A Coyle
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL, USA
Artif Organs 34:93-7. 2010..2 vs. 1.6), and survival (63% vs. 65%). Our initial results demonstrate that morbidly obese patients with end-stage heart failure with a contraindication for transplant may successfully undergo implantation of an LVAD for DT...
Utilization of acoustic signatures to identify HeartMate XVE device end-of-lifeMark S Slaughter
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
J Heart Lung Transplant 26:579-83. 2007..In this study we assess a non-invasive technique using acoustic signals generated from the HeartMate XVE LVAD to potentially identify impending device end-of-life issues...
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialRoberto Bolli
Divisions of Cardiovascular Medicine, University of Louisville, Louisville, KY 40202, USA
Lancet 378:1847-57. 2011..We undertook a phase 1 trial (Stem Cell Infusion in Patients with Ischemic cardiOmyopathy [SCIPIO]) of autologous CSCs for the treatment of heart failure resulting from ischaemic heart disease...
Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist DeviceMark S Slaughter
Advocate Christ Medical Center, Oak Lawn, Ill 60453, USA
J Thorac Cardiovasc Surg 133:1573-80. 2007..3 m(2). Results of the multicenter clinical trial are reviewed...
Minimally invasive mitral valve repair using the da Vinci robotic systemAntone J Tatooles
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
Ann Thorac Surg 77:1978-82; discussion 1982-4. 2004..CONCLUSIONS: Mitral valve repair can be successfully performed with the da Vinci robotic system. Long-term follow-up is needed to determine the durability of the repair compared with a standard sternotomy approach...
Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapySoon J Park
Division of Cardiac Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Circ Heart Fail 5:241-8. 2012..The primary hypothesis of the current study is that trial patients enrolled after the initial data cohort would have better clinical outcomes...
Blood trauma testing for mechanical circulatory support devicesGuruprasad A Giridharan
Department of Bioengineering, University of Louisville, Louisville, KY, USA
Biomed Instrum Technol 45:334-9. 2011..Standardization of hemolysis testing procedures and transparency of results may enable better blood trauma characterization of MCS devices to facilitate the FDA 510(k) and PMA submission processes and improve clinical outcomes...
Embol-X intra-aortic filtration system: capturing particulate emboli in the cardiac surgery patientMichael A Sobieski
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
J Extra Corpor Technol 37:222-6. 2005..Clearly, the reduction of particulate matter by as much as 95% justifies its use in cardiac surgery patients identified with an increased pre-operative embolic risk...
Improvement in early oxygen uptake kinetics with left ventricular assist device supportChad M Feldman
Internal Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
ASAIO J 54:406-11. 2008..7 seconds to 35.8 +/- 13.3 seconds (p = 0.046) with LVAD support. Improved oxygen kinetics suggests improved peripheral utilization of oxygen, and may offer an additional clinical parameter to predict the likelihood of sustained recovery...
Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?Michael A Sobieski
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
ASAIO J 54:203-6. 2008..Despite the significant reductions in IL-6 and PNE, there was no effect on clinical outcomes. Additional studies are needed to demonstrate a clinically significant effect on patient outcomes...
Home discharge experience with the Thoratec TLC-II portable driverMark S Slaughter
Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
ASAIO J 53:132-5. 2007..There were no readmissions for device malfunction, emergency battery utilization or back-up unit use. These results demonstrate that the Thoratec TLC-II portable driver is safe, reliable, and can be effectively managed at home...
Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist deviceMark S Slaughter
Cardiac Surgery Research, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
ASAIO J 54:115-9. 2008..Three nonfatal bleeding events but no thromboembolic events were observed. Fibrinolytic responses initially increase after LVAD implantation but then gradually normalize...
Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacementChad M Feldman
Advocate Christ Medical Center, Mechanical Assist Device Program, Oak Lawn, Illinois 60453, USA
J Heart Lung Transplant 25:1410-2. 2006..We report on two patients with bioprosthetic aortic valve replacement for aortic insufficiency at the time of HeartMate II LVAD insertion...
Coronary artery fistula: 64-slice computed tomographic delineation and correlation with multiplane transesophageal echocardiography and surgical findingsJonathan K Joshi
Radiology Medicine Surgery, University of Louisville, Louisville, KY, USA
Echocardiography 29:E69-71. 2012..Findings were ultimately confirmed at cardiac catheterization. Coronary steal was clinically diagnosed and she underwent surgical ligation and resection of the fistula and aneurysm. Her subsequent course was uncomplicated...
Is female sex an independent risk factor for perioperative transfusion in coronary artery bypass graft surgery?Matthew L Williams
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, KY, USA
J Am Coll Surg 212:362-6. 2011..We evaluated female sex as an independent risk factor for red blood cell transfusion in CABG, while accounting for hematocrit...
The Thoratec mobile computer: initial in-hospital and outpatient experienceMichael A Sobieski
Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
ASAIO J 50:373-5. 2004..Data were successfully obtained in all cases. Documentation of programmed settings and driver operation was achieved without difficulty...
Antegrade versus Retrograde Cerebral Protection in Repair of Acute Ascending Aortic DissectionMatthew L Williams
Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky, USA
Am Surg 78:349-51. 2012..514 and 0.956, respectively). No compelling evidence for an advantage to either antegrade or retrograde cerebral perfusion was detected. Further study with a focus on neurologic outcomes is warranted...
Destination therapy: the future is arrivingMark S Slaughter
Department of Cardiothoracic Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
Congest Heart Fail 11:155-6. 2005
Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist deviceMark S Slaughter
Division Cardiac Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 W. 95th Street, Suite 205, Oak Lawn, IL 60453, USA
ASAIO J 49:611-2. 2003..We believe that PEG placement should be cpnsidered in patients with an LVAD with swallowing difficulties or who are debilitated are not meeting their caloric requirements...
Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory supportSanjeev Aggarwal
University of Louisville, Cardiovascular Innovation Institute, Division of Thoracic and Cardiovascular Surgery, Louisville, KY 40202, USA
Expert Rev Cardiovasc Ther 6:1223-35. 2008..However, access to revascularization and VAD support, including percutaneous VADs, is currently limited and must improve to more effectively treat AMI-CS patients...
